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deaths from bladder cancer were observed 
in this group (3) and because the expected 
number of deaths from bladder cancer was 
also low, and 112 men who had been lost to 
follow-up before December 31, 1989. This 
left 590 exposed workers; of these, 271 had 
died between 1946 and 1989, leaving 319 
men for extended follow-up through 
December 31, 2003. Follow-up was trun-
cated when a participant reached age 85 
years because of the poor quality of death 
certification for those older than that age. 
We traced 305 (96%) of the 319 workers 
alive in 1989, yielding a total of 17 754 
man-years at risk in this analysis.
Information was available on date and 
place of birth, dates of start and termina-
tion of employment, job history (including 
categories of exposure to selected amines), 
and the last known address. As described by 
Rubino et al. (2), who used knowledge of 
carcinogenicity of aromatic amines, workers 
with any of the following four categories of 
aromatic amine exposure were considered 
at highest risk and are grouped into one 
category for this analysis: a-naphthylamine 
manufacture, b-naththylamine manufac-
ture, benzidine manufacture, and mixed 
manufacture of benzidine and naphthyl-
amine (n = 133). The other three categories 
of workers included workers never involved 
in manufacture, but only in use of naph-
thylamine and benzidine (n = 134), workers 
with intermittent contact with naphthyl-
amine and benzidine (n = 276), and workers 
who were involved only in manufacture of 
fuchsin or o-toluidine (n = 47). Ten workers 
exposed to both benzidine and/or naph-
thylamine and to fuchsin and/or o-toluidine 
manufacture were considered in the first 
category. For all time-related factors (dura-
tion and time since first or last exposure), 
we grouped all four categories of exposure 
together. Further verification of vital status 
was obtained from registries of current 
residence, and death certificates were 
obtained from registration offices at the 
municipality of death.
The expected numbers of deaths from 
bladder cancer and other causes were com-
puted by use of national mortality rates (9) 
from 1951 to 1980 and regional mortality 
rates (10) when available (ie, from 1981 to 
2003), stratified in 5-year age groups from 
Aromatic amines are a group of well-known 
bladder carcinogens. Exposure to aromatic 
amines has been discontinued in most coun-
tries, but relatively little data are available on 
the patterns of long-term health risks many 
years after cessation of exposure (1,2–8). A 
substantial excess of mortality from bladder 
cancer was observed in a cohort of 664 
workers who were heavily exposed to aro-
matic amines between 1922 and 1972 in a 
dyestuff factory in northern Italy (2–4). In 
the most recent published follow-up of this 
cohort through December 1989, 49 bladder 
cancer–specific deaths were observed overall, 
compared with 1.6 expected (standardized 
mortality ratio [SMR] = 30.4) (4). In more 
detailed analyses by time of exposure, risk was 
still elevated (SMR = 14.8; seven deaths vs 
0.5 expected) 20 years or more after exposure 
stopped. Along with two other studies, one 
in the United States (5) and one in Wales 
(6), this cohort study is among the few 
providing information on bladder cancer 
risk after exposure specifically to o-toluidine.
In this analysis, we included an addi-
tional 14 years of observation of this Italian 
cohort through 2003 by including more 
than 30 years of follow-up since last expo-
sure to aromatic amines for all workers to 
provide unique, long-term information on 
bladder cancer risk among workers after 
extremely heavy exposure to several aro-
matic amines many years in the past.
Further details on the study methods, 
including exposure definition, have been 
previously published (2–4). The original 
cohort definition was approved in the 1970s 
by the Institutional Board of the Department 
of Occupational Health, University of 
Turin, according to the regulations at the 
time. The study did not involve direct con-
tact with the workers. Briefly, the original 
cohort was composed of 906 men who had 
worked at least 1 year in the dyestuff plant 
between 1922 and 1972 and who were alive 
in 1946. We did not consider 204 men who 
were not directly involved in jobs entailing 
exposure to aromatic amines because no 
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deaths from bladder cancer and other causes were computed by use of national 
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were 394 deaths, compared with 262.7 expected (standardized mortality ratio = 
1.50, 95% confidence interval = 1.36 to 1.66). Overall, 56 deaths from bladder cancer 
were observed, compared with 3.4 expected (standardized mortality ratio = 16.5, 
95% confidence interval = 12.4 to 21.4). The standardized mortality ratio for bladder 
cancer increased with younger age at first exposure and increasing duration of 
exposure. Although the standardized mortality ratio for bladder cancer steadily 
decreased with time since exposure stopped, the absolute risk remained approxi-
mately constant at 3.5 deaths per 1000 man-years up to 29 years after exposure 
stopped. Excess risk was apparent 30 years or more after last exposure.
J Natl Cancer Inst 2010;102:1096–1099
 at Bib U
niv del D








jnci.oxfordjournals.org   JNCI | Brief Communication 1097
20–24 to 80–84 years. For the period 
1946–1950, we used rates of 1951–1954. 
Because retirement or change of job may in 
some cases be caused by bladder cancer, 
and for consistency with our previous 
reports (3,4), deaths that occurred within 
3 years of stopping exposure were consid-
ered with those occurring during 
exposure.
From the numbers of observed and 
expected deaths, we calculated the stan-
dardized mortality ratios for selected causes 
of death and their corresponding 95% con-
fidence intervals (CIs) by use of the Poisson 
distribution for observed deaths (11). 
Standardized mortality ratios were adjusted 
for age (in 5-year age groups) and for 
5-year calendar period.
Overall, there were 394 observed deaths 
from all causes in the cohort for the entire 
period of follow-up from 1946 through 
2003 vs 262.7 expected (SMR = 1.50, 95% 
CI = 1.36 to 1.66) (Table 1). There were 56 
deaths from bladder cancer compared with 
ConteXt anD CaVeatS
Prior knowledge
Aromatic amines are well-known bladder 
carcinogens.
Study design
Cohort study of dyestuff workers with a 
follow-up of more than 30 years since last 
exposure to aromatic amines. Mortality 
from all causes and from bladder cancer 
was assessed.
Contribution
In this cohort, more deaths from all causes 
were observed (n = 394) than expected (n = 
262.7) and more deaths from bladder can-
cer were observed (n = 56) than expected 
(n = 3.4). Although the standardized mor-
tality ratio for bladder cancer steadily 
decreased with time since exposure 
stopped, the absolute risk for bladder can-
cer remained approximately constant at 3.5 
deaths per 1000 man-years up to 29 years 
after exposure stopped.
Implications
Increased risk of bladder cancer persisted 
30 years or more after last exposure.
Limitations
More than 10% of the original cohort was 
lost to follow-up before 1989. 
From the Editors
 
Table 1. Numbers of observed and expected deaths and standardized mortality ratios 
(SMRs) with 95% confidence intervals (CIs) for selected causes of death in a cohort of 
dyestuff workers from northern Italy: 1946–2003*
Cause of death No. observed No. expected SMR (95% CI)
Cancer type
 Oral cavity, pharynx 7 2.6 2.67 (1.07 to 5.50)
 Esophagus 5 2.0 2.45 (0.80 to 5.72)
 Stomach 10 9.6 1.04 (0.50 to 1.92)
 Intestines 14 7.1 1.99 (1.08 to 3.33)
 Liver 6 3.1 1.93 (0.71 to 4.20)
 Larynx 11 2.7 4.12 (2.05 to 7.36)
 Lung 27 21.3 1.27 (0.84 to 1.85)
 Pleura 2 0.5 3.75 (0.45 to 13.55)
 Prostate 4 4.4 0.91 (0.25 to 2.33)
 Bladder 56 3.4 16.45 (12.42 to 21.36)
 Lymphopoietic 3 4.8 0.62 (0.13 to 1.81)
All cancer types 163 77.3 2.11 (1.80 to 2.46)
All cancer types excluding bladder 107 73.9 1.45 (1.19 to 1.75)
Other causes of death
 Ischemic heart disease 23 39.9 0.58 (0.37 to 0.87)
 Cerebrovascular disease 39 27.4 1.42 (1.01 to 1.95)
 Cirrhosis 42 11.3 3.72 (2.68 to 5.03)
 COPD 20 10.9 1.84 (1.12 to 2.84)
 Injuries 21 16.5 1.27 (0.79 to 1.94)
All causes of death 394 262.7 1.50 (1.36 to 1.66)
* The deaths and man-years at risk from individuals aged 85 years or older were excluded. COPD = chronic 
obstructive pulmonary disease.
3.4 expected (SMR = 16.5, 95% CI = 12.4 to 
21.4). Excess mortality was observed 
for all alcohol-related cancers, including 
cancer of the oral cavity and pharynx (SMR = 
2.67, 95% CI = 1.07 to 5.50), esophagus 
(SMR = 2.45, 95% CI = 0.80 to 5.72), intes-
tines (SMR = 1.99, 95% CI = 1.08 to 3.33), 
liver (SMR = 1.93, 95% CI = 0.71 to 4.20), 
and larynx (SMR = 4.12, 95% CI = 2.05 to 
7.36). Similarly, excess mortality was 
observed for other alcohol-related causes, 
including cerebrovascular disease (SMR = 
1.42, 95% CI = 1.01 to 1.95), cirrhosis 
(SMR = 3.72, 95% CI = 2.68 to 5.03), and 
injuries (SMR = 1.27, 95% CI = 0.79 to 
1.94), but not for ischemic heart disease 
(SMR = 0.58, 95% CI = 0.37 to 0.87). Of 
the 130 excess deaths, 53 were caused by 
bladder cancer alone and approximately 75 
were attributed to the complex of alcohol-
related causes. Some excess mortality was 
also observed for cancer of the lung (SMR = 
1.27, 95% CI = 0.84 to 1.85) and chronic 
obstructive pulmonary disease (SMR = 
1.84, 95% CI = 1.12 to 2.84). There were 
two deaths from pleural cancer, both among 
workers who had started working in the 
plant after age 35 years.
We determined the numbers of observed 
and expected deaths from bladder cancer, 
all other cancers, and all causes according 
to time since last exposure, age at first 
exposure, and duration of exposure (Table 2). 
For time since last exposure and duration 
of exposure, workers contributed relevant 
person-time to multiple exposure cate-
gories. In this cohort, there were 16 excess 
bladder cancer deaths during exposure 
(SMR for bladder cancer = 57.8, 95% CI = 
33.0 to 93.9), 15 from 1 through 9 years 
since stopping (SMR = 28.5, 95% CI = 16.0 
to 47.1), 12 from 10 through 19 years 
(SMR = 14.7, 95% CI = 7.8 to 25.2), eight 
from 20 through 29 years (SMR = 11.0, 
95% CI = 5.1 to 20.9), and two for 30 years 
or more after last exposure (SMR = 3.3, 
95% CI = 0.7 to 9.7). The standardized 
mortality ratio for bladder cancer was 
higher in workers with exposure at younger 
age and decreased with increasing age at 
first exposure. Furthermore, the risk of 
bladder cancer was higher in workers with 
10 years or more of exposure as compared 
with those with less than 10 years. For other 
cancers and for deaths overall, no consistent 
pattern of risk with time since last exposure, 
age at first exposure, or duration of expo-
sure was observed.
In an analysis of bladder cancer deaths 
by job categories, we found 33 bladder 
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Table 2. Mortality from bladder cancer, all other cancers, and all causes by time since exposure stopped, age at first exposure, and 
duration of exposure in a cohort of dyestuff workers from northern Italy: 1946–2003*
Category





















Time since last exposure
 During exposure 16 0.3 57.8 (33.0 to 93.9) 11 9.3 1.2 (0.6 to 2.1) 56 39.0 1.4 (1.1 to 1.9) 6123
 1–9 y 15 0.5 28.5 (16.0 to 47.1) 23 13.3 1.7 (1.1 to 2.6) 98 52.8 1.9 (1.5 to 2.3) 4145
 10–19 y 13 0.9 14.7 (7.8 to 25.2) 28 18.4 1.5 (1.0 to 2.2) 100 68.2 1.5 (1.2 to 1.8) 3550
 20–29 y 9 0.8 11.0 (5.1 to 20.9) 18 15.9 1.1 (0.7 to 1.8) 74 52.8 1.4 (1.1 to 1.8) 2335
 ≥30 y 3 0.9 3.3 (0.7 to 9.7) 27 17.0 1.6 (1.0 to 2.3) 66 49.8 1.3 (1.0 to 1.7) 1601
Age at first exposure
 <25 y 15 0.6 24.7 (13.8 to 40.8) 20 15.1 1.3 (0.8 to 2.1) 73 44.1 1.7 (1.3 to 2.1) 5817
 25–34 y 18 1.2 15.4 (9.1 to 24.3) 38 24.7 1.5 (1.1 to 2.1) 110 80.6 1.4 (1.1 to 1.6) 6198
 ≥35 y 23 1.6 14.1 (9.0 to 21.2) 49 34.1 1.4 (1.1 to 1.9) 211 138.0 1.5 (1.3 to 1.8) 5739
Duration of exposure
 <10 y 15 1.6 9.3 (5.2 to 15.3) 59 37.2 1.6 (1.2 to 2.0) 191 124.7 1.5 (1.3 to 1.8) 11207
 10–19 y 21 0.9 24.4 (15.1 to 37.2) 22 18.6 1.2 (0.7 to 1.8) 111 73.1 1.5 (1.3 to 1.8) 4014
 ≥20 y 20 0.9 21.7 (13.2 to 33.5) 26 18.1 1.4 (0.9 to 2.1) 92 64.9 1.4 (1.1 to 1.7) 2533
* CI = confidence interval; exp = expected; obs = observed; SMR = standardized mortality ratio.
cancer deaths among workers directly 
involved in manufacture of naphthylamine 
and benzidine (SMR = 48.7, 95% CI = 33.5 
to 88.3), seven among utilizers (ie, workers 
involved in the manufacture of azo dyes as 
well as production of benzidine and naph-
thylamine salts and homologs) (2) (SMR = 
8.7, 95% CI = 3.5 to 17.9), and 10 among 
those intermittently exposed (SMR = 6.0, 
95% CI = 2.9 to 11.1) (Table 3). We also 
found excess bladder cancer deaths among 
manufacturers of fuchsin or o-toluidine (six 
observed deaths; SMR = 22.5, 95% CI = 
8.3 to 49.0).
With approximately two-thirds of the 
members of the cohort deceased during 
the 58-year follow-up and with more than 
30 years of follow-up since last exposure to 
aromatic amines, these workers provide a 
unique opportunity to analyze the long-
term health effects of extremely heavy oc-
cupational exposure to aromatic amines. 
More than 96% of workers who were alive 
on December 31, 1989, were traced through 
2003. A possible limitation of the study is 
losses to follow-up before 1989. In fact, 
112 workers had previously been lost to 
follow-up. Although this may have intro-
duced some bias, loss to follow-up cannot 
explain the extreme excess of bladder can-
cer risk observed in this cohort or the 
observed time–risk relation. For time- 
related variables (ie, duration of exposure 
and time since last exposure), we dynami-
cally assigned relevant person-time for each 
worker to different exposure categories 
Table 3. Mortality from bladder cancer by job category in a cohort of dyestuff workers 
from northern Italy: 1946–2003*
Job category No. Obs No. Exp SMR (95% CI)
Naphthylamine and benzidine manufacture 33 0.7 48.7 (33.5 to 68.3)
Naphthylamine and benzidine use 7 0.8 8.7 (3.5 to 17.9)
Intermittent contact with naphthylamine and benzidine 10 1.7 6.0 (2.9 to 11.1)
Fuchsin or o-toluidine manufacture 6 0.3 22.5 (8.3 to 49.0)
* CI = confidence interval; exp = expected; obs = observed; SMR = standardized mortality ratio.
(11). Reliability and validity of Italian death 
certification since the 1950s are satisfactory 
(9,12).
The relative risk (RR; which was calcu-
lated as SMR) for bladder cancer declined 
steadily (from a high of RR = 57.8 during 
exposure to RR = 3.3 for ≥30 years after 
stopping exposure). The absolute risk, 
however, remained approximately constant 
at approximately 3.5 excess deaths from 
bladder cancer per 1000 man-years up to 
29 years after stopping exposure and was 
still 1.9 per 1000 man-years 30 years or 
more after last exposure. This pattern par-
allels that of lung cancer risk observed after 
smoking cessation, which levels off at ap-
proximately the level reached at the time of 
stopping (13). Likewise, an immediate 
decrease in the relative risk for bladder cancer 
is apparent after stopping smoking, but risk 
does not reach the level of never-smokers 
even 25 years after cessation (14). In this dye-
stuff worker’s cohort, the number of excess 
bladder cancer cases began to decline after 
20 years or more since cessation of exposure 
to aromatic amines. This observation has, 
therefore, important implications for the 
long-term surveillance of workers heavily 
exposed to aromatic amines in the past.
Our study provides additional evidence 
for the carcinogenicity of o-toluidine on 
the human bladder. Workers included in 
this category were primarily exposed to 
o-toluidine because the 10 workers who 
were exposed to both o-toluidine and ben-
zidine and/or naphthylamine were excluded 
from this group. Apart from previous 
reports on this cohort (2,3), cancer risk has 
been examined in two other occupational 
cohorts of workers exposed to o-toluidine. 
In one cohort of 1749 workers at a chemi-
cal plant in Western New York State (5), 
seven participants were diagnosed with 
bladder cancer cases among the 708 
workers exposed to both o-toluidine and 
aniline vs 1.08 expected (standardized inci-
dence ratio = 6.48). In the second cohort of 
2160 workers in a factory manufacturing 
chemicals for the rubber industry in Wales 
(6), three bladder cancer deaths were 
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observed in the toluidine department, with 
a trend of a borderline statistically signifi-
cant increased risk with duration of em-
ployment. On the basis of those data, an 
International Agency for Research on 
Cancer (IARC) Working Group recently 
concluded that o-toluidine is a human 
carcinogen (1).
This is the first report from this cohort 
of dyestuff workers to present data on 
causes of death other than bladder cancer. 
A widespread and substantial excess was 
observed for all alcohol-related cancers 
and other major alcohol-related diseases 
(15) but not for lymphoid neoplasms, 
which have been inversely related to 
alcohol drinking (15). Some excess mor-
tality was also observed for lung cancer and 
chronic obstructive pulmonary disease. 
We did not find a consistent relation with 
time since first or last exposure or with 
duration of exposure for any of these 
causes of death. It is therefore more likely 
that the excess mortality for those causes 
was a result of heavy alcohol drinking, 
smoking, and other lifestyle characteristics 
rather than occupational exposure. 
Likewise, the two observed deaths from 
pleural cancer were in workers who had 
started working in the plant after age 
35 years, suggesting that exposures to 
asbestos in jobs held before employment 
in the plant under study may be relevant.
At the 1981 follow-up of this cohort (3), 
we assumed an additive model between 
exposure to aromatic amines and tobacco 
smoking and found a 13%–14% cumula-
tive risk of death from bladder cancer, 
which is in agreement with results from the 
2003 follow-up, with about two-thirds of 
the cohort deceased. The absolute risk of 
bladder cancer death among those younger 
than 85 years approached 10% (95% CI = 
7% to 12%). This result lends support to 
the validity of the additive model for occu-
pational exposure to aromatic amines and 
tobacco smoking on bladder carcinogenesis 
(16). It also confirms the excess of bladder 
cancer risk in this cohort of workers who 
were heavily exposed to aromatic amines 
because the number of deaths from bladder 
cancer was more than twice that from lung 
cancer or ischemic heart disease.
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